Biogen | 266.6000 / -1.20% |
Date/Time | 03/03 / 22:00 |
Chg. / Chg.(%) | -3.2500 / -1.20% |
Bid | 265.8100 / 1000 |
Ask | 272.9800 / 100 |
Open | 267.8000 |
Previous Close | 269.8500 |
High | 269.2800 |
Low | 263.8000 |
Volume [USD] | 156,447,424.6185 |
Volume [Units] | 1,037,052 |
Price fixings | 4126 |
ISIN | US09062X1037 |
Security | BIIB |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 221.450 | ![]() |
458 |
Xetra | 221.10 | ![]() |
248 |
Moscow | 19,620.00 | ![]() |
162 |
Stuttgart | 219.750 | ![]() |
100 |
gettex | 220.600 | ![]() |
16 |
Vienna Globa.. | 221.35 | ![]() |
5 |
Frankfurt | 220.1000 | ![]() |
2 |
München | 218.95 | ![]() |
0 |
Hamburg | 219.55 | ![]() |
0 |
Düsseldorf | 221.35 | ![]() |
0 |
Berlin | 221.35 | ![]() |
0 |
Hannover | 219.55 | ![]() |
0 |
Lang & Schwa.. | 221.300 | ![]() |
|
NASDAQ | 266.6000 | ![]() |
1,037,052 |
IEX | 266.52 | ![]() |
57,154 |
Cboe US | 266.81 | 46,672 | |
London Inter.. | 267.40 | 1,103 | |
Mexico | 5,588.99 | ![]() |
200 |
News
- Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
14:00 - GlobeNewswire - Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
13:47 - GlobeNewswire - Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
13:25 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
03/01/2021 / 22:00 - GlobeNewswire